Global
vaccines market forecast to grow to $34 billion by 2012 "Vaccines
have emerged as one of the most lucrative segment in the global pharmaceutical
industry, according to a new report added to the offering of Research
and Markets. Overall, the global vaccine market is expected to register
revenues in excess of $34 billion by 2012. With a projected compound
annual growth rate (CAGR) of over 13% during 2009-2012, the industry
will emerge as the fastest growing therapy area. The US and Europe
represent the two largest global vaccine markets and will continue
experiencing healthy growth rate in future. .." thepharmaletter.com
(site accessed Dec 09)
Stem
cell treatment for sight loss could be in use by 2012 "A
Stem cell treatment for the leading cause of sight loss in older people
could be in widespread use within six years, according to researchers.
The Edinburgh Science Festival will later this week hear that scientists
want to start patient trials of the treatment for age-related macular
degeneration (AMD) by 2012 ..." news.scotsman.com (site accessed
April 2009)
One
in three Britons may be obese by 2012 "...A
third of all British adults -- some 13 million people -- will be obese
by 2012 if current trends continue, jeopardising their health and
straining healthcare budgets ... Almost half of them will be from
low income and disadvantaged communities, widening the health gap
between the haves and have-not ..." reuters.com (site accessed
Dec 08)
See also:
Europe: Obesity to hit one third of kids by 2012 "Over
a third of children aged five to 13 will be overweight or obese by
2012, according to a report published today (7 July) by research analysts
Datamonitor ... Datamonitor blamed above-average consumption of "energy-dense,
indulgence food and drinks", including savoury snacks and ice
cream. The analysts also pointed to non-food factors including lack
of exercise and the importance of travelling by car to out-of-town
retail parks and leisure venues ..." just-food.com (site
accessed July 2008)
Malaria
vaccine may be available in 2012 "A
vaccine against the parasitic disease malaria cut illnesses by more
than half in field trials and could be safely given with other childhood
inoculations, two studies have reported. The vaccine, which will begin
a third and final phase of clinical trials early next year, could
become the first to protect children from malaria, which kills nearly
1 million people worldwide every year ..." latimes.com (site
accessed Dec 2008)
Death
from HIV/AIDS to peak in 2012 "The
number of deaths due to HIV and AIDS is expected to peak in 2012,
according to a report released by the World Health Organization. In
its new Global Burden of Disease publication on Monday, the UN health
agency expects deaths caused by HIV and AIDS to rise from 2.2 million
in 2008 to a maximum of 2.4 million in 2012, before declining to 1.2
million in 2030 ..." xinhuanet.com (site accessed Oct 08)
See
also: Therapeutic vaccine for Aids by 2012 "A
French scientist awarded the Nobel Prize for medicine for discovering
the AIDS virus immediately predicted there would be a "therapeutic
vaccine" for the disease within four years ... A therapeutic
vaccine prevents disease from flourishing after it has taken hold
..." telegraph.co.uk (site accessed Oct 08)
See
also: HIV experts say 20 million in Asia could be infected
by 2012 "The
number of people in Asia with the AIDS virus may more than double
over the next five years unless governments do more to stop the spread
of HIV, officials said yesterday. About 8.6-million people in Asia
are infected with HIV..." The Calgary Sun (site accessed
Apr 2007)
See
also: 500,000 people in Uganda to be targeted for routine AIDS
testing and counselling by 2012 "...
Currently, there are an estimated 1.1 million HIV infected individuals
and this number is projected to increase to 1.8 million by 2012 at
the current rate of of 135,000 new infections annually ...”
NewVision.co.ug (site accessed Jan 2007)
China's
Hepatitis B market to double by 2012 "
... Decision Resources puts the current count of people in China with
chronic hepatitis B at 80 million, though other reports estimate the
total is 50% higher – 120 million. That constitutes almost 10%
of the population. Part of the reason behind the high dollar value
of drugs for this population is that the nucleoside/nucleotide analogue
class of drugs often used to treat the disease must be given long
term, often for the rest of a patient’s life. In most cases,
these drugs are effective, suppressing the viral count, but the disease
reappears as soon as treatment is discontinued ..." seekingalpha.com
(site accessed Sep 2008)
USA:
Nutritional supplements to reach $8.5 billion in 2012 "
... Helping to protect the category as consumers tighten their discretionary
spending belts are the strong preventive health care angle of supplements
and the market’s sizeable component of better-off demographics
including aging Baby Boomers. Nutritional Supplements in the U.S.
reports on numerous other positive factors also at play, including
industry efforts to promote supplements as more essential than ever
in weak economic times since they can help to avert the need for much
costlier prescription drugs and medical treatments ..." packagedfacts.com
(site accessed Aug 08)
Global
market for cancer drugs expected to exceed $78 billion by 2012 "
... Cancer vaccines and antiangiogenics will record the fastest growth
rate between 2007 and 2012 ..." researchandmarkets.com (site
accessed Aug 2008)
See
also: $8
billion dollar cancer vaccine market by 2012 "
...
As many as five new vaccines to treat cancer may soon
be available, creating an $8 billion dollar cancer vaccine market
by 2012, representing over half of the $15 billion total vaccine market
that will exist that year, according to (market research firm) Kalorama.
...." Earthtimes.org (site accessed Feb 2007)
See also: Global
Market for Cancer Immunotherapy Worth $37.2 Billion by 2012
Pharmalive.com (site accessed Mar 2007)
Gastrointestinal
disorders in 2012 "Gastrointestinal
(GI) disorders are set to affect over 250 million people in the seven
largest pharma markets, by 2012. As generations of people become more
obese and consume increasingly poor diets then so too will the number
of people suffering from these disorders rise ... " expertdoctor.blogspot.com
(site accessed Sep 2007)
Global
epigenomics market to reach $4.1 billion by 2012 "$4.1
Billion by 2012? is the major finding of a market report on the global
epigenomics market published by BCC Research. The report identified
three key market segments that will be commercially important in the
field of epigenomics in the next 5 years: research tools, cancer diagnostics,
and cancer therapeutics." www.epigeneticsnews.com (site accessed
May 2007)
South
Korea will start to use human embryonic stem cells in actual therapy
around 2012 "The first target will be
hard-to-cure diseases caused by nerve cell disorders as scientists
are continuing to make breakthroughs in the field'' The Korea
Times (site accessed Sept 2006)
NHS
Computer system to link general practitioners (GPs) in England to
nearly 300 hospitals by 2012 "It
involves an online booking system, a centralised medical records system
for 50m patients, e-prescriptions and fast computer network links
between NHS organisations ....senior academics question whether the
National Programme for IT has been properly designed and rigorously
reviewed to meet the needs of 24-hour health care." BBC News
(site accessed June 2006)
Worldwide
homecare systems expected to reach $1.2 billion by 2012 "The
homecare market is changing. New services needed in the home include
intravenous (IV) therapy, pain control, and basic needs services delivery.
Delivery of new services depends on systems integration." Genetic
Engineering News (site accessed May 2006)
